S-1 - Eterna Therapeutics Inc. (0000748592) (Filer)

1 min to read

S-1 – Eterna Therapeutics Inc. (0000748592) (Filer)

Filed: 2023-04-17 AccNo: 0001140361-23-018529 Size: 488 KB
Source: S-1 – Eterna Therapeutics Inc. (0000748592) (Filer)

Viatris Announces Agreements on Remaining Planned Divestitures … – Viatris

Viatris Announces Agreements on Remaining Planned Divestitures ... Viatris Source: Viatris Announces Agreements on Remaining Planned Divestitures ... - Viatris
Berenson Acquisition I Signs NRA Ahead of Extension Vote

Berenson Acquisition I in an 8-K said it entered into a non-redemption agreement with one or more unaffiliated third parties in exchange for...
VAM Investments SPAC B : Press Release – Interim Financial … – Marketscreener.com

VAM Investments SPAC B : Press Release – Interim Financial ... Marketscreener.com Source: VAM Investments SPAC B : Press Release –...
Welsbach Technology Metals Acquisition Postpones Extension Vote 24 Hours

Welsbach Technology Metals Acquisition today said the Sept. 28 meeting for shareholders to vote on a deadline extension has been...
SPAC Churchill Capital V to redeem its shares and not complete … – Seeking Alpha

SPAC Churchill Capital V to redeem its shares and not complete ... Seeking Alpha Source: SPAC Churchill Capital V to redeem...